World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
129
Citations
101567
World Ranking
2522
National Ranking
1420

Philip J. Mease publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philip J. Mease sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,080 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philip J. Mease D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philip J. Mease sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 129 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Philip J. Mease is affiliated with the University of Washington in the United States and has contributed extensively to research in medicine, with a strong focus on rheumatology and immunology. Their work intersects multiple subfields including hematology, psychiatry and mental health, and economics and econometrics, reflecting a multidisciplinary approach to complex health conditions.

Their research primarily covers topics related to spondyloarthritis studies and treatments, psoriasis treatment and pathogenesis, rheumatoid arthritis research and therapies, and autoimmune and inflammatory disorders. Additional topics addressed in their work include fibromyalgia and chronic fatigue syndrome research, health systems and economic evaluations, quality of life, and dermatology and skin diseases.

The most frequent venues for their publications are:

  • Annals of the Rheumatic Diseases
  • The Journal of Rheumatology
  • Lara D. Veeken
  • Rheumatology and Therapy
  • RMD Open

Philip J. Mease has collaborated with a number of researchers, often co-authoring with:

  • Laura C. Coates
  • Dafna D. Gladman
  • Iain B. McInnes
  • Alexis Ogdie
  • Joseph F. Merola

Among their recent publications are:

  • "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021," published in 2022 in Nature Reviews Rheumatology
  • "Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial," published in 2020 in The Lancet
  • "Psoriatic arthritis," published in 2021 in Nature Reviews Disease Primers
  • "Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial," published in 2020 in The Lancet
  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update," published in 2024 in Annals of the Rheumatic Diseases

Their scientific contributions have centered on advancing understanding and treatment options for inflammatory and autoimmune diseases, particularly psoriatic arthritis. The emphasis on clinical trials and treatment guidelines in their publications highlights their role in bridging research and clinical application.

Best Publications

  • 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

    Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits

  • The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity.

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg

  • Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

    William Taylor;Dafna Gladman;Philip Helliwell;Antonio Marchesoni

  • Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

    Philip J Mease;Bernard S Goffe;James Metz;Ann VanderStoep

  • Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial

    Larry W. Moreland;Michael H. Schiff;Scott W. Baumgartner;Elizabeth A. Tindall

  • Psoriatic arthritis: epidemiology, clinical features, course, and outcome

    D D Gladman;C Antoni;P Mease;D O Clegg

  • 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg;Don L. Goldenberg

  • Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia

    Frederick Wolfe;Daniel J. Clauw;Mary Ann Fitzcharles;Don L. Goldenberg

  • Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

    Philip J. Mease;Alan J. Kivitz;Francis X. Burch;Evan L. Siegel

  • Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

    Philip P.J. Mease;Dafna D.D. Gladman;Christopher C.T. Ritchlin;Eric E.M. Ruderman

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Laura C. Coates;Arthur Kavanaugh;Philip J. Mease;Enrique R. Soriano

  • Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    Iain B McInnes;Philip J Mease;Bruce Kirkham;Arthur Kavanaugh

  • Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.

    Leslie J. Crofford;Michael C. Rowbotham;Philip J. Mease;I. Jon Russell

  • Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.

    Philip J. Mease;Iain B. McInnes;Bruce Kirkham;Arthur Kavanaugh

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • Treatment recommendations for psoriatic arthritis

    C. T. Ritchlin;A. Kavanaugh;D. D. Gladman;P. J. Mease

  • Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.

    Philip Mease

  • Epidemiology of psoriatic arthritis in the population of the United States.

    Joel M. Gelfand;Dafna D. Gladman;Philip J. Mease;Nana Smith

Frequent Co-Authors

Dafna D. Gladman
Dafna D. Gladman Toronto Western Hospital
Arthur Kavanaugh
Arthur Kavanaugh University of California, San Diego
Philip S. Helliwell
Philip S. Helliwell University of Leeds
Christopher T. Ritchlin
Christopher T. Ritchlin University of Rochester Medical Center
Vibeke Strand
Vibeke Strand Stanford University
Iain B. McInnes
Iain B. McInnes University of Glasgow
Oliver FitzGerald
Oliver FitzGerald University College Dublin
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Robert Landewé
Robert Landewé University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up numerous possibilities beyond becoming a doctor. Many students consider online degrees that offer flexibility and diverse career outcomes. For those already working as registered nurses, online rn to bsn programs without clinicals provide an accessible way to earn a bachelor’s degree while balancing work and life demands.

If your interests are in advancing further, adn to np bridge programs help registered nurses achieve nurse practitioner status with a flexible, online curriculum. These advanced roles often lead to higher salaries and greater autonomy in patient care.

Alternatively, non-clinical roles are also growing in demand. For those interested in nutrition, online nutrition degrees offer pathways into wellness coaching, food science, and community health education. Healthcare administration is another critical area, with leadership opportunities accessible through online mha programs cahme accredited by top industry bodies.

These educational routes ensure that students can align their studies with their career interests, whether in direct patient care, wellness, or health management.

Best Scientists Citing Philip J. Mease

Trending Scientists

Recently Published Articles